Healthcare - Biotechnology - NASDAQ - US
$ 7.46
-0.798 %
$ 54.4 M
Market Cap
-0.55
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
45.65%
EBIT
Estimate
21.50%
Net Income
Estimate
--60.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Kezar Life Sciences, Inc.
KZR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart KZR
EBIT FORECAST
EBIT Forecast Chart KZR
NET INCOME FORECAST
Net Income Chart KZR